Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial. (nature.com)

Authors: Raab MS … Rasche L Journal: Nature Medicine Published: 2026-06-25 DOI: https://doi.org/10.1038/s41591-026-04471-x